When Treatment Becomes the Illness

My experience sits in the uncomfortable space between what patients are routinely told about psychiatric medication and what can, in many cases, actually unfold over time. It is not simply a story of adverse effects—it is a story about the consequences of incomplete information, overconfidence in simplified narratives, and a medical culture that too often defaults to explanation rather than investigation when things go wrong.

I was prescribed the antidepressant Sertraline for situational panic attacks following a house fire when I was younger, and remained on it for approximately 13 years. During that time, I was never meaningfully informed about the possibility of physiological dependence, nor about the potential difficulty of stopping the drug after long-term use. The phrase “safe and effective” was presented as if it were a stable, universal truth, rather than a context-dependent conclusion drawn from limited and biased data.

There was no discussion of what happens when the brain adapts to a drug over more than a decade. No acknowledgement that removing that drug might not be a neutral act. No mention of protracted withdrawal, or that stopping could result in a severe and prolonged destabilisation of the nervous system. Informed consent, in any meaningful sense, was absent.

When I eventually came off the SSRI, it was done through a rapid taper that bore no relation to the duration of my use. What followed was not a return of my original symptoms, but the onset of something far more severe, complex, and debilitating.

Almost immediately, I began to experience intense and persistent surges of physiological anxiety and panic. These were not thoughts or worries in the conventional sense. They were full-body events—overwhelming waves of adrenaline that arose without psychological trigger, accompanied by a profound sense of internal threat. They were not responsive to reasoning, reassurance, or standard psychological strategies because they were not primarily psychological in origin.

Alongside this, I developed widespread neurological and sensory disturbances. I experienced constant “electric” sensations throughout my body, moving unpredictably through my arms, legs, hands, and across my head and face. These were often painful, presenting as burning, tingling, or sharp nerve-like sensations. My muscles began to twitch involuntarily, with fasciculations and spasms becoming a daily occurrence. At times, my facial muscles would contract and twitch without warning.

One of the most severe and distressing symptoms I experienced was akathisia. It is often described clinically as restlessness, but that description is profoundly inadequate. What I experienced was an intense, unrelenting inner agitation combined with a powerful urge to escape my own body, alongside a compulsion to move that made stillness feel intolerable. At its worst, it generated intense suicidal urges—not from hopelessness, but from a desperate need to escape the sensation itself. It was not psychological distress in any conventional sense; it was a physical state that overrode any attempt at control. It is difficult to overstate how severe and destabilising this symptom has been for three years.

Sleep became almost impossible at times. I went through prolonged periods of insomnia, sometimes sleeping only a few hours across several days. When I did manage to fall asleep, I was frequently jolted awake by hypnic jerks—sudden, violent awakenings accompanied by adrenaline surges. The cumulative effect of this sleep deprivation was profound, amplifying every other symptom and eroding my ability to cope.

Cognitively, I experienced significant impairment. I developed episodes of derealisation, where the world felt distant, flat, and unreal. My ability to concentrate deteriorated and I often felt mentally foggy and disconnected. Tasks that once required little effort became difficult or impossible.

These were not isolated symptoms. In total, I have experienced over 30 additional debilitating symptoms ranging from gastrointestinal disturbances and temperature dysregulation to severe nausea, headaches, muscle pain, internal vibrations, and sensory hypersensitivity. The breadth of these symptoms points not to a single system failure, but to a global dysregulation of the nervous system.

Despite how distinct and severe this presentation was, it was not recognised as withdrawal. Instead, it was repeatedly interpreted through existing diagnostic categories. I was told that I was relapsing, that I had developed a new mood disorder, and at one stage I was diagnosed with Functional Neurological Disorder.

This reflex to reinterpret rather than reassess had major consequences. Instead of stabilising the situation, I was placed into a cycle of escalating intervention. Over six months, I was prescribed and switched between 11 different psychiatric drugs—including antipsychotics, mood stabilisers, and benzodiazepines—in an attempt to manage symptoms that were, in reality, being driven by withdrawal and nervous system destabilisation. Each new drug introduced further variables, further side effects, and further instability.

This is not simply a matter of individual clinical error. It reflects a broader systemic issue: when the prevailing model does not adequately account for a patient’s experience, the patient is made to fit the model rather than the model being questioned.

The course of my condition has been profoundly nonlinear. Symptoms fluctuate in waves. There have been periods, sometimes lasting several days or longer, where symptoms have reduced dramatically. During these windows, the anxiety has subsided and the electrical sensations have quietened. These periods are clear demonstrations that my system is capable of stabilisation.

However, these windows are often followed by sudden and intense returns of symptoms. This oscillation creates a state of ongoing uncertainty, where improvement cannot be trusted and recovery feels unstable.

The impact on my life has been profound. I have been left effectively disabled. Basic functions such as sleeping, resting, maintaining a routine, and engaging in daily activities have been significantly impaired. I have lost my career, my house, my friends, and much of my family. I have had to rely heavily on the support of my parents and my fiancée for three years now, where independent functioning has not been possible.

Beyond the symptoms themselves, there is a deeper issue of accountability and transparency. At no point prior to treatment was I given a realistic account of the potential risks associated with long-term use and stopping the original SSRI. The absence of this information is not a minor oversight—it is a failure of informed consent.

Had I been informed about the possibility of severe and prolonged withdrawal and the need for a slow, carefully managed taper after long-term use, I would have made different decisions. At the very least, I would have approached the process with caution and awareness. Instead, I entered into treatment under a framework that did not adequately reflect the full range of possible outcomes.

In the absence of clear and informed medical guidance, I was forced to seek understanding elsewhere. Through patient-led communities, I found individuals from across the world describing nearly identical symptom patterns and trajectories. I owe my life to this community.

The fact that patients must rely on informal global networks to understand what is happening to them should be a cause for serious reflection within the medical community. It raises questions about how knowledge is generated, how it is validated, and how long it takes for emerging realities to be integrated into practice.

My experience has fundamentally altered my life. It has affected my physical health, mental wellbeing, independence, and trust in medical care. While I have had periods of improvement, and those periods matter, they exist within a broader context of instability that should never have been this severe or prolonged.

This is not an argument against treatment, but against oversimplification. It is a call for intellectual honesty. Psychiatric drugs are not inert substances. They produce real, lasting changes in the brain and body. To present them without fully acknowledging the potential consequences of those changes is to provide patients with an incomplete picture.

Patients deserve more than reassurance. They deserve transparency, nuance, and the ability to make genuinely informed decisions. Until that standard is met, others will continue to enter treatment as I did—trusting the system and unprepared for the reality that may follow.